LEP and metabolic disease: Our findings are also concordant with fetal metabolic programming studies in humans and rodent models which have lately shown that lower LEP DNA methylation levels in blood, placenta, VAT, liver and muscle are associated with a risk for obesity and metabolic diseases in the offspring [10,44,23].